92 related articles for article (PubMed ID: 9796973)
1. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
Shimazui T; Oosterwijk E; Akaza H; Bringuier P; Ruijter E; van Berkel H; Wakka JO; van Bokhoven A; Debruyne FM; Schalken JA
Clin Cancer Res; 1998 Oct; 4(10):2419-24. PubMed ID: 9796973
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.
Shimazui T; Kojima T; Onozawa M; Suzuki M; Asano T; Akaza H
Oncol Rep; 2006 May; 15(5):1181-4. PubMed ID: 16596183
[TBL] [Abstract][Full Text] [Related]
3. Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma.
Shimazui T; Oosterwijk-Wakka J; Akaza H; Bringuier PP; Ruijter E; Debruyne FM; Schalken JA; Oosterwijk E
Eur Urol; 2000 Sep; 38(3):331-8. PubMed ID: 10940709
[TBL] [Abstract][Full Text] [Related]
4. Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts.
Tani T; Laitinen L; Kangas L; Lehto VP; Virtanen I
Int J Cancer; 1995 Dec; 64(6):407-14. PubMed ID: 8550243
[TBL] [Abstract][Full Text] [Related]
5. Cadherins and integrins in renal cell carcinoma: an immunohistochemical study.
Markovic-Lipkovski J; Brasanac D; Müller GA; Müller CA
Tumori; 2001; 87(3):173-8. PubMed ID: 11504373
[TBL] [Abstract][Full Text] [Related]
6. Cadherin-6: a new prognostic marker for renal cell carcinoma.
Paul R; Necknig U; Busch R; Ewing CM; Hartung R; Isaacs WB
J Urol; 2004 Jan; 171(1):97-101. PubMed ID: 14665853
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin expression in renal cell cancer and its significance in metastasis and survival.
Katagiri A; Watanabe R; Tomita Y
Br J Cancer; 1995 Feb; 71(2):376-9. PubMed ID: 7841055
[TBL] [Abstract][Full Text] [Related]
8. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma.
Paul R; Ewing CM; Robinson JC; Marshall FF; Johnson KR; Wheelock MJ; Isaacs WB
Cancer Res; 1997 Jul; 57(13):2741-8. PubMed ID: 9205085
[TBL] [Abstract][Full Text] [Related]
9. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Umbas R; Isaacs WB; Bringuier PP; Schaafsma HE; Karthaus HF; Oosterhof GO; Debruyne FM; Schalken JA
Cancer Res; 1994 Jul; 54(14):3929-33. PubMed ID: 7518346
[TBL] [Abstract][Full Text] [Related]
10. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
11. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
[TBL] [Abstract][Full Text] [Related]
12. N-cadherin is differentially expressed in histological subtypes of papillary renal cell carcinoma.
Behnes CL; Hemmerlein B; Strauss A; Radzun HJ; Bremmer F
Diagn Pathol; 2012 Aug; 7():95. PubMed ID: 22888908
[TBL] [Abstract][Full Text] [Related]
13. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
14. Complex cadherin expression in renal cell carcinoma.
Shimazui T; Giroldi LA; Bringuier PP; Oosterwijk E; Schalken JA
Cancer Res; 1996 Jul; 56(14):3234-7. PubMed ID: 8764114
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ksp-cadherin during kidney development and in renal cell carcinoma.
Thedieck C; Kuczyk M; Klingel K; Steiert I; Müller CA; Klein G
Br J Cancer; 2005 Jun; 92(11):2010-7. PubMed ID: 15886705
[TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
18. Role of complex cadherins in cell-cell adhesion evaluated by spheroid formation in renal cell carcinoma cell lines.
Shimazui T; Schalken JA; Kawai K; Kawamoto R; van Bockhoven A; Oosterwijk E; Akaza H
Oncol Rep; 2004 Feb; 11(2):357-60. PubMed ID: 14719067
[TBL] [Abstract][Full Text] [Related]
19. CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma.
Fischer C; Georg C; Kraus S; Terpe HJ; Luedecke G; Weidner W
Anticancer Res; 1999; 19(2C):1513-7. PubMed ID: 10365135
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
